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  The purpose of this research is to develop a method for assessing in vivo 
protein-protein interactions in cultured cells that are permissive to Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV) infection. The Non 
Structural Protein 3 (NSp3) expressed by PRRSV was used as a prey to capture 
interacting cellular proteins in protein cell lysates using a Pull-Down assay. 
Interacting proteins were resolved by SDS-PAGE, extracted and identified by 
means of mass spectrometry. Different alternatives have been tested to create 
the optimal conditions for performing the technique that will allow further 
confirmation of virus-host cells protein-protein interaction in PRRSV permissive 
cells. 
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REVIEW OF LITERATURE: PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME VIRUS 
Etiology: 
The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is an 
enveloped, spherical, single-stranded positive-sense RNA virus 40-60 nm in diameter. 
PRRSV is in the order of Nidovirales, family Arteriviridae, genus Arterivirus (Botner, 
1994). There are two types of PRRSV viruses, one is the European isolate and the 
other is the North American isolate. Sequence analysis showed that the virus isolates 
are evolving by random mutation and intragenic recombination (Cho, 2006). Other 
arteriviruses include equine arteritis virus (EAV), lactate dehydrogenase-elevating virus 
(LDV), and simian hemorrhagic fever virus (SHFV). EAV, LDV and SHFV were isolated 
and characterized in 1960s and 1970s; however, PRRSV was not isolated or 
characterized until the 1990s (Snijder, 1998).  
The polycistronic 3’-polyadenlated and 5’-capped arterivirus genome is 12-16 kb 
long. The arterivirus genomes have a 5’ nontranslated region (NTR) of 156-224 
nucleotides, and a 3’ NTR of 59-117 nucleotides. Arteriviruses contain 10-15 known 
open reading frames (ORFs). Specifically, PRRSV contains eight ORFs (Xiang-Jin, 
1995).  Arteriviruses also contain two large ORFs named 1a and 1b, which take up 
three-quarters of the genome at the 5’ proximal end (Snijder, 2013).  
With very strict host cell specificity, LDV has been found to grow but not replicate 
in primary cultures of mouse macrophages, and SHFV and PRRSV have been found to 
replicate in primary macrophage cultures of simian and porcine origin as well as in 
African green monkey kidney cells (MA-104) and their derivatives (CL2621 and MARC-
2 
145) (Snijder, 1998). Arteriviruses assemble by budding of nucleocapsids into the lumen 
of the endoplasmic reticulum and/or Golgi apparatus, and are released from cells via 
exocytosis. Although little is known about the replication cycle of arteriviruses, the 
replication cycle begins with the expression of non-structural protein genes encoded by 
ORF1a and ORF1b.  Both arteriviruses and coronaviruses show discontinuous 
subgenomic mRNA transcription of their genomes, which is one reason why they are 
grouped together in the order of Nidovirales (Snijder, 1998). 
Arteriviruses are spherical, enveloped virions with a diameter of 40-60 nm, 
containing an isometric core particle of 25-35 nm in diameter. Furthermore, arteriviruses 
contain a nucleocapsid protein, the N protein, with a molecular mass between 12-15 
kDa, which represents 20-40% of the protein content of the virion. Immunoprecipitation 
of N from purified PRRSV showed that the protein is present as disulfide-linked 
homodimer. The non-glycosylated M protein of arteriviruses is the most conserved 
structural protein, playing a role in the formation of disulfide bridges in receptor binding 
(Snijder, 1998).  
The severity of diseases resulting from arteriviruses varies on the specific virus 
and strain as well as the condition and age of the animal infected. However, a variety of 
symptoms from arteriviruses infections generally include respiratory distress, 
hemorrhagic fever, and necrosis of small muscular arteries. Additionally, abortion in 
pregnant animals, and a persistent presence of the virus in the semen of infected male 




History of PRRSV 
 Porcine Reproductive and Respiratory Syndrome (PRRS), while the etiology was 
unknown at the time, emerged in 1987 in the United States and Canada (Mystery 
Disease); and, immediately impacted economics in the swine industry at a cost of 
approximately $560 million US dollars per year in the 1990’s (Cho, 2006).  By 1991, 
PRRS had become widespread in Europe after similar clinical outbreaks were reported 
in Germany in 1991. PRRSV as the viral agent for PRRS was identified by researchers 
in The Netherlands and the United States, determining that there are two strains of 
PRRSV: North American and European strains (Forsberg, 2002).   
Clinical Aspects of PRRSV 
 Clinical signs of PRRSV in swine include severe reproductive failure, post-
weaning pneumonia, growth reduction, decreased performance, and increased 
mortality. Specific reproductive failures include third-trimester abortions, premature 
parturition, and higher levels of fetal losses. The degree of clinical PRRS varies 
depending on the virulence of the PRRSV isolate as well as the animal age and 
presence of bacterial co-infections (Cho, 2006).  
 Abortion rates from PRRSV infection vary greatly, and were reported as 3% in 
The Netherlands, and over 80% in Spain. Other symptoms include periocular edema, 
conjunctivitis, and eyelid edema, which were reported in Spain, Germany, and England. 
In Europe and Canada, but not the United States, a blue discoloration of ears, teats, 
snout, and ventral cervical skin, vulva, and abdomen was reported. Early signs of a 
PRRSV infection include influenza-like symptoms such as conjunctivitis, depression, 
lethargy, and anorexia lasting up to 2 weeks. Although death in older pigs in not 
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common with a PRRSV infection, the virus can persist in infected herds and lead to 
difficulty in breeding and growing pigs. In adult pigs, the signs tend to be milder and 
consist of anorexia lasting 5-7 days, with an increased respiratory rate, listlessness, and 
hyperexcitability. Additionally, adult pigs may show changes in body temperatures 
ranging between 104°-106°F. Chronic pneumonia is also a complication of PRRSV and 
contributes to an increase in mortality (Meulenberg, 2000).  
 Clinical manifestations are more severe in newborn and nursing pigs than in 
adult pigs especially in the form of respiratory distress. A respiratory disorder called 
“thumping” can occur with PRRSV infection in nursing pigs, which is caused by a virus 
induced interstitial pneumonia. Newborn and nursing pigs also experience mouth 
breathing, listlessness, lateral recumbency, paddling, sneezing, and vomiting. The 
mortality rate of preweaning pigs could be up to 50-60% due to starvation or diarrhea.  
 The clinical signs in breeding pigs include late term abortions, stillbirths (50-
70%), and premature farrowing. Recovery can start up to 2-3 weeks after infection and 
can result in a poor conception rate and a slower return to heat. Some herds have been 
found to recover back to normal breeding routines after an outbreak, whereas other 
herds show persistent effects including smaller litter sizes, and piglets born with a risk of 
developing other diseases including atrophic rhinitis, enzootic pneumonia, and more 
severe forms of Salmonella and other bacterial infections (Rossow, 1998) 
Diagnosis of PRRSV 
 Diagnosis of PRRSV can be determined by clinical signs or laboratory based 
testing including histopathology, serology, virus isolation and RT-PCR in clinical 
samples obtained from sows and/or fetuses. However, diagnosis based on clinical signs 
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alone is not ideal because of the great variety of clinical manifestations of PRRS from 
pig to pig and from herd to herd. Additionally, secondary bacterial infections as well as 
other diseases confound the clinical diagnosis of PRRS. Overall, if swine herds are 
showing more than a 20% rate of stillbirths, late-term abortions, pre-mature farrowing 
higher that 8%, or an increase in mortality rates of pigs within the first week of life 
(>25%), then PRRS should be suspected. Histopathologically, a characteristic sign of 
PRRSV infection of lungs includes the manifestation of interstitial pneumonia as 
thickened alveolar septa with macrophages present (Figure 1). However, infection of 
lungs with H1N1 and H3N2 strains of Influenza virus also result in thickened alveolar 
septa with macrophage infiltration. 
 
Figure 1. (a) Microscopic section of a normal pig lung. (b). Microscopic section of a lung from a 
pig infected with PRRSV after 10 days. Necrotic debris and inflammatory cells are present in the 
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alveolar spaces. (c). Microscopic section of a lung from a pig infected with PRRSV after 28 
days. (d). Microscopic section of a lung from a pig infected with PRRSV after 28 days with both 
M. hyopneumonia and PRRSV-induced pneumonia (Thacker, 1999). 
 
Antibody detection in fetal fluids or pre-colostral blood of stillborn and newborns 
as well as an increase in antibody titers in serum samples collected 3 weeks apart are 
indicative of PRRSV infections. For PRRSV surveillance purposes, a minimum of 30% 
of the herd should be serologically tested in order for a 95% confidence in the detection 
of PRRSV infections. Virus isolation is ideal for samples collected from acutely infected 
pigs presenting respiratory signs. PRRSV can be detected in lungs, spleen, lymph 
nodes and serum. Infectious virus can also be obtained from the lung, spleen, heart, 
blood, and thoracic fluids samples obtained from stillborn and aborted fetuses for up to 
6-8 weeks after infection (Rossow, 1998).   
PRRSV Transmission 
 Both infected pigs and contaminated semen contribute as direct routes for 
PRRSV transmission. PRRSV has been found in blood, semen, saliva, feces, milk, and 
colostrum of infected pigs. Vertical and horizontal transmissions of PRRSV have been 
reported. Indirect routes of PRRSV transmission include fomites such as boots and 
coveralls; transport vehicles; insects including mosquitoes and houseflies; avian and 
non-porcine mammalian species and possibly waterfowl; and aerosols (Cho, 2006). 
Aerosols are of high importance in the transmission of PRRSV, which is affected by 
high humidity, low temperatures, and low wind speed (Rossow, 1998).  
 Although exact information on the incubation period of PRRS is unknown, a 37 
day lag time has been reported between the virus entry and manifestation of signs of 
the disease. Herds can remain infected for at least 2 months after signs of PRRS start 
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to fade away. The presence of the virus for a long period of time in infected herds is a 
source for new infections (Rossow, 1998). 
Treatment and control 
 Avoiding the introduction of PRRSV to a herd by means of quarantine is one 
method of controlling PRRS. This also includes testing incoming pigs, restricting 
visitors, changing boots and clothes after dealing with the pigs, and keeping stray 
animals and rodents away. However, PRRSV can be transmitted as an aerosol, so 
control through quarantine may not be entirely effective. Other means of control include 
disposing of placentas, fetuses, and dead piglets immediately; cleaning farrowing areas 
thoroughly after abortions or pre-mature farrowing; and disinfecting all entrances/exits of 
breeding houses and transport vehicles (Rossow, 1998)  
 Vaccination against PRRSV also prevents the spread of disease in pigs. 
Modified-live virus (MLV) commercial PRRSV vaccines have been available since 1994, 
such as Ingelvac PRRS MLV (Boehringer Ingelheim Vetmedica, Inc) (Opriessnig, 2002). 
Experiments have shown that vaccination with MLV vaccines in pigs reduces clinical 
signs following a PRRSV challenge. Additionally, herd closure, sow acclimation, and 
mass exposure can help to reduce the risk of PRRSV shedding and spreading (Cano, 
2007).  
PRRS virus  
 Mature viral particles produced from PRRSV infected cells are composed of an 
envelope of 40-60 nm in diameter, surrounding a 20-30 nm isometric capsid that 
includes an approximately 15 kb linear positive-stranded RNA genome. Mature virions 
are released by exocytosis after being formed by the budding of preformed 
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nucleocapsids into the lumen of the smooth endoplasmic reticulum and/or Golgi 
apparatus (Dea, 2000).  
PRRSV, as an enveloped virus, has a survivability outside the host that can be 
affected by temperature, pH, and exposure to detergents. PRRSV can survive for over 
four months at temperatures between -70 to -20°C, and remain stable at pH ranges 
between 6.5 and 7.5. Detergents such as lipid solvents like chloroform and ether 
effectively disrupt PRRSV’s viral envelope (Cho, 2006).   
The PRRSV genome has nine open reading frames, which are transcribed in 
cells as subgenomic mRNAs. ORF1a and ORF1b are at the 5’ end of the genome and 
represent about 75% of the viral genome encoding non-structural proteins that are 
involved in replication of the virus (Dea, 2000).   
PRRSV has a restricted cell tropism in vivo and in vitro. The virus can infect well-
differentiated cells of the monocyte-macrophage lineage in vivo including particular 
porcine alveolar macrophages (PAM). PRRSV also targets interstitial macrophages in 
the heart, thymus, spleen, Peyer’s patches, hepatic sinusoids, renal medullary 
interstitium and the adrenal gland. PRRSV RNA and nucleocapsid protein N were also 
found by in situ hybridization (ISH) and immunohistochemistry in testicular germ cells, 
endothelial cells in the heart, interdigitating cells in the thymus, dendritic cells in the 
spleen and Peyer’s patches (Music, 2010).  
PAM cells and blood-derived monocytes are the only porcine cells that can be 
used to propagate PRRSV in vitro. However, MARC-145 and CL2621, which are 
subclones of the MA104 monkey kidney line, are of non-porcine origin permissive cell 
lines to PRRSV infection (Snijder, 1998).   
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The virus enters cells via receptor-mediated endocytosis, this entry mechanism 
was confirmed by Duan et al in 1998. In the same study, it was shown that PRRSV 
interacts with heparin sulphate during binding to the cell surface, to sialoadhesins for 
binding and internalization, and to vimentin. Higher expression of CD163, which is most 
likely used for viral uncoating, also interacts with PRRSV on macrophages. PRRSV 
infections induce apoptosis in cells in vivo as well as in vitro, which ultimately manifests 
as DNA fragmentation and activation of caspases (Music, 2010).  
PRRSV Protein Synthesis  
The PRRSV genome encodes structural and non-structural (NS) proteins. The 
major structural protein of PRRSV is encoded by ORF5, a 25 kDa envelope 
glycoprotein known as GP5. The 18-19 kDa unglycosylated membrane protein M is 
encoded by ORF6, and the 15 kDa nucleocapsid protein N is encoded by ORF7. The N 
protein is highly antigenic, making it a prime target for detection of PRRSV infections 
(Dea, 2000). 
The life cycle of the virus begins with the expression of the large replicase gene 
complex encoded by ORF1a and ORF1b, which translate polyproteins pp1a and pp1ab, 
respectively (Figure 2). The pp1a polyprotein is cleaved at eight sites by viral and 
cellular proteases, yielding nine non-structural proteins (NSps) including NSp1α, 
NSp1β, and NSp2-NSp8.  Cleavage of pp1ab polyprotein yields NSp9-NSp12. Although 
little is known about the function of NSps of PRRSV, besides that together they show 
replicase, protease, and polymerase functions, it is known that NSps generated from 
the pp1a polyprotein express proteolytic activities; and that NSps generated from pp1ab 
polyprotein are involved with transcription and replication functions (Music, 2010). 
 
Figure 2. Genome organization of PRRSV containing the 5’ proximal replicase ORFs 1a and 1b 
with downstream ORFs that encode glycoproteins GP2
nucleocsapsid (N) towards the 3’ end. 
 
Impact of the disease caused by PRRSV
 Since the emergence of PRRSV in the 1980’s
has been recognized as a disease with major economic implications to the swine 
industry (Albina, 1997). According to an economic assessment by the American 
Association of Swine Veterinarians in 2012, the total cost of productivity losses due to 
PRRSV in the United States was estimated at $664 million yearly.  This figure shows a 
significant increase from the estimated $560 million annual cost in the 1990’s to 2005. 
Therefore, PRRSV continues to be a critical virus to study as eradication efforts have 
failed to lower the economic burden
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-5, the envelope (E), membrane (M), and 
Adapted from Fang, 2010.  
 
-1990’s in the United States, PRRS 
 of the disease (Neumann, 1995).  
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OBJECTIVE OF RESEARCH 
 The objective of this research is to develop a method to identify PRRSV-host 
protein-protein interactions in cells that are permissive to the virus infection. The method 
is based on a Pull-Down Assay that is designed to “capture” cellular proteins that bind to 
PRRSV NSp3. Virus-host protein-protein interactions are vital to understanding 
mechanisms underlying infection that result in manifestation of disease. Here, we are 
studying the interactions of PRRSV NSp3, a viral protein involved in replication, with 
cellular protein and its potential role in regulation of virus induced apoptosis. In addition, 
establishing a Pull-Down technique to study protein-protein interactions in PRRSV in 
general is of utmost importance for future research.  
APPROACH 
 NSp3, a known protein expressed by PRRSV during infection, was used as a 
“prey” protein in a Pull-Down Assay to “capture” interacting cellular proteins in cell 
lysates obtained from PRRSV-permissive cells. The Pull-Down Assay protocol used 
here (Pierce® GST Protein Interaction Pull-Down Kit) uses a Glutathione S-Transferase 
(GST) based technique (Figure 3), where agarose gel beads bind to GST-tagged 
proteins. The GST-tagged protein in this study was PRRSV NSp3 whereas GST protein 
was used as control. GST-NSp3 was expressed in E.coli as a fusion protein and tested 
for the ability to bind to glutathione coated beads. Cell lysates were prepared under 
different conditions from MARC-145 cells that are permissive to PRRSV infection. After 
testing the ability of GST-NSp3 to bind cellular proteins by incubating coated beads with 
cellular lysates, beads were recovered and bound material separated by SDS-PAGE. 
Identification of bound cellular proteins was performed by tryptic in-gel digestion of 
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these proteins that interacted with the bait protein was conducted and identified by 
means of mass spectrometry.  
 
Figure 3. This schematic representation of a Pull-Down Assay describes the protocol in a 
simplified three-step process. First, the agarose glutathione bead bound to a glutathione affinity 
ligand (i.e.: GST) is prepared with the “bait” protein (i.e.: NSp3). Next, that “bait” protein, in this 
case NSp3, is used to “fish” for “prey” proteins in a mammalian cell lysate, in this case from 
PRRSV permissive MARC-145 cells. Finally, these “captured” “prey” proteins are eluted and 
proteins identified by Mass Spectrometry. Adapted from Pierce® GST Protein Interaction Pull-
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PROCEDURES AND RESULTS 
PRRSV NSp3 Synthesis using an E. coli Expression System: Cloning of GST-NSp3 
fusion protein 
The gene encoding for PRRSV NSp3 was amplified by means of the polymerase 
chain reaction (PCR) using primers NSp3_pENTR_For 5’caccatgggaggcccgcacctc 3’ 
and NSp3_pENTR_Rev 5’gaattcttagtgatggtgatggtgatgctcaagaagggaccc 3’ targeting 
plasmid pFL12 that contains a full-length DNA copy of PRRSV. The PCR conditions 
were as follows: incubation at 95°C for 2 minutes, 35 cycles of 95°C for 30 s, 58°C for 
30 s, and 68°C for 2 minutes, and final extension step of 68°C for 3 minutes. The 
amplification was undertaken in a thermal cycler (Mastercycler, Eppendorf, Westbury, 
NY). The resulting PCR fragment was eluted from a 1% agarose gel using the QIAEX II 
Gel Extraction Kit (Qiagen, Valencia, CA), and directionally cloned into pENTR/D- 
TOPO vector (Invitrogen, Carlsbad, CA) following instructions of the manufacturer. After 
cloning, recovered plasmids were sequenced to assess fidelity of the cloned NSp3 
gene. The NSp3 gene was transferred to vector pDEST15 (Invitrogen) that contains a 5’ 
end GST fusion tag, using homologous recombination. The reaction containing 7µL of 
pENTR/D- TOPO-NSp3, 1µL of pDEST15, and 2µL of LR clonase was incubated for 1 
hour at 25°C. After incubation, 1µL of proteinase K was added to the reaction that was 
further incubated for 10 minutes at 37°C. The reaction mix was used to transform TOP-
10 chemically competent E. coli cells (Invitrogen) that were plated in Terrific Broth agar 
plates in the presence carbenicillin for selection of bacteria containing pDEST15-NSp3. 
Carbenicillin resistant bacteria were selected from the plates and grown overnight at 
37°C in Terrific Broth-carbenicillin for isolation of plasmid DNA. After purification plasmid 
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DNA was sequenced to assess the fidelity of GST-NSp3 fusion. pDEST15-NSp3 was 
used for expressing the fusion protein. 
Expression of GST-NSp3 fusion protein 
 BL21 (DE3) E. coli cells (Invitrogen) were transformed with plasmids pDEST15 
and pDEST15-NSp3 harboring GST or GST-NSp3 fusion genes, respectively.  Briefly; 
2µL of Beta-mercaptoethanol (βME) were added to 100µL of BL21cells containing 
microcentrifuge tubes labeled GST (control) or GST-NSp3. Cells were incubated on ice 
for 10 minutes, and 1µL of pDEST15 or pDEST15-NSp3 was added to each tube 
incubating on ice for 30 minutes. Next, BL21 cells were subject to a heat-shock at 42°C 
for 45 seconds and placed back on ice for additional 2 minutes. Super Optimal Broth 
medium (SOC), 250µL, was added to the transformed cells and incubated while shaking 
for 1 hour at 37°C. Cells, 150µL were plated in Terrific Broth-agar plates containing 100 
ug/ml of carbecillin, and incubated overnight at 37°C. Four colonies were selected from 
the plates and grown for 21 hours at 37°C with shaking in MagicMedia (Invitrogen) to 
induce expression and harvested by centrifugation at 3,200 x g for 15 min. The cell 
pellets were treated with 1ml of CelLytic buffer (Sigma Aldrich, St. Louis, MO) in the 
presence of 20µL of lysozyme and 5mL of 10x Tris Buffered Saline (TBS) according to 
manufacturer’s large scale extraction protocol and saved at -200C.  Cell lysates were 
analyzed on a NuPAGE® Novex 12% Bis-Tris Gel (Invitrogen) by a discontinuous SDS-
PAGE system. MagicMark XP Protein Standard (Invitrogen) was used as a molecular 
weight standard. For SDS-PAGE, 13µL of cell lysates were mixed with 5µL of NuPage 
LDS Sample Buffer, 2µL of NuPage Reducing Agent, making a total volume of 20µL 
Samples were heated at 70°C for 10 minutes and ran for 50 minutes at 200V, 100mA. 
Gels were stained with Coomassie blue stain (
blots, separated proteins were transferred to p
(Invitrogen). Briefly, blotting pads were soaked
containing 12.5mL of NuPAGE
(Invitrogen), 25mL of methano
were soaked in methanol for 30 seconds, rinsed with water 3 times, and soaked in 
transfer buffer before transferring. The set up for the W
pads, filter paper, gel, PVDF activated membrane, and two additional blotting pads
(Figure 4). The assembled unit was then placed in 
and the transfer was completed by applying 30 volts for 1 hour.
Figure 4. Assembly of SDS-PAGE gels for transferring of proteins to PVDF membranes using 
the XCell II™ Blot module (Invitrogen).
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 for 5 minutes in a transfer buffer 
® Transfer Buffer (Invitrogen), 250µL of antioxidant 
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estern blot consisted of 2 blotting 






Western blots were developed using a Western Breeze Chemiluminescent 
Detection Kit (Invitrogen) according with instructions provided by the manufacturer.  
Briefly, after transfer, PVDF membranes were blocked for 4 hours at room-temperature, 
with shaking, in blocking buffer containing 5mL of ultrapure water, 2mL of 
Blocker/Diluent A, and 3mL of Blocker/Diluent B. After blocking, PVDF membranes 
were rinsed 3 times with ultrapure water for 5 minutes each time and incubated 
overnight with a mouse anti-GST antibody (Invitrogen) in a buffer containing 7mL of 
ultrapure water, 2mL of Blocker/Diluent A, 1mL of Blocker/Diluent B and 4µL (1:2500 
dilution) of the anti-GST antibody. After exposure to the primary antibody, the 
membrane was washed 3 times for 5 minutes each wash with a washing buffer 
containing 150mL of ultrapure water and 10mL of the Antibody Wash. After washes, the 
membrane was then incubated in 10mL of anti-mouse secondary antibody solution for 
30 minutes at room temperature, with shaking. After washing the excess of secondary 
antibody as described above, protein bands were detected using CDP-star 
chemiluminescent substrate provided with the kit and subsequently exposed to an X-ray 
film (Kodak X-OMAT LS film, Kodak, Rochester, NY). 
 The results from the Western immunoblot are shown in Figure 5. Lanes 1 and 2 
show the expression of GST-NSp3 fusion proteins and lanes 3 and 4 show the 
expression of GST proteins.  
Figure 5. Detection of GST-NSp3 and GST proteins expressed in E. col
detected in a Western blot using Western




i. Proteins were 
 Breeze Chemiluminescent Immunodetection Kit 




Production of Glutathione-GST-NSp3 beads and detection of NSp3 binding proteins
 After confirmation of expression of GST-NSp3 and GST proteins obtained with 
the E.coli based expression system, these “bait proteins” were immobilized on the 
surface of glutathione agarose beads. Here we used a Pierce™ GST Protein Interaction 
Pull-Down Kit (Pierce-Thermo Fisher Scientific).  Glutathione Agarose was used for 
binding GST-fused NSp3 to the beads. Glutathione is linked by its central sulfhydryl to 
agarose beads and using affinity chromatography, glutathione-agarose permits rapid 
and highly selective binding and eventually purification of glutathione binding enzymes 
such as glutathione S-transferase (GST). The overall scheme used for the production of 
glutathione-GST-NSp3 beads and identification of NSp3 binding proteins is summarized 
in the following figure. 
 
Figure 6. Summary of the procedure used to detect and identify cellular proteins that bind to 




Immobilization of GST-NSp3 
A- Equilibrate Glutathione Agarose 
Glutathione agarose resin were thoroughly resuspended by vortexing and 50µL of 
the slurry was transferred to 1.5mL microcentrifuge tubes (Note: glutathione agarose is 
supplied as a 50% slurry. Settled resin volume per assay is 25µL). Then, 400µL of the 
wash solution buffer (1:1 solution containing TBS [25 mM Tris-HCL, 0.15 M NaCl, pH 
7.2]-Pull-Down Lysis Buffer) were added to the tubes. Caps were closed and tubes 
inverted several times to equilibrate the glutathione agarose resin. Tubes were then 
spun at 1250 × g for 30 seconds to 1 minute. Wash solution was discarded. The 
process was repeated for 5 times. 
B- Immobilize Bait Protein  
After equilibration, GST-NSp3 fusion proteins were added to the glutathione resin. 
Five different binding conditions were tested as described in Table 1.  
Combination Volume of GST-NSp3 prep. (µL) 
Volume of TBS 
(µL) 
1 50 450 
2 150 350 
3 200 300 
4 300 200 
5 400 100 
Table 1. Binding of GST-NSp3 and GST proteins to GST beads. Combination of proteins and 
binding buffer tested.  
GST-NSp3 and TBS were mixed and tubes were incubated at 4°C for at least 30 
minutes with gentle rocking motion on a rotating platform (Note: Maximal binding may 
require a longer incubation time, which should be determined for each new GST-tagged 
fusion protein). After incubation, tubes were spun at 1250 × g for 30 seconds to 1 
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minute. Supernatant was transferred to a fresh tube labeled “bait flow-through” and 
placed on ice. After binding the resin was washed five times using 400µL of the wash 
solution buffer followed by centrifugation 1250 × g for 30 seconds to 1 minute each time. 
Western immunoblots were used to assess binding of GST-NSp3 and GST to the 
glutathione beads using an anti-GST antibody. Briefly, beads were mixed with 6µL of 
SDS-loading buffer and 1µL of reducing agent (Life Technologies), boiled for 10 
minutes, and spun at 1250 × g for 30 seconds. Protein containing supernatants were 
then resolved by Western blots following procedures explained above (Table 1). 
Obtained data showed that lysate-TBS combination 4 (Table 2), containing 300µL of E. 
coli derived lysate expressing GST-NSp3 protein, showed the highest binding as 
determined by the highest intensity of GST-NSp3 signal relative to the signals observed 
with the other combinations. 
Lane 1 2 3 4 5 6 7 8 9 10 11 12 
Sample MW PC S-1 S-2 S-3 S-4 S-5 B-1 B-2 B-3 B-4 B-5 
Table 2. After binding, supernants (S) and beads (B) from the 5 combinations described in table 
1 were resolved by SDS-PAGE followed by a Western blot to detect GST-NSp3 proteins. The 
highest band intensities were detected in lanes 6 and 11 that represent combination 4 of lysate-
TBS.  
The immobilization of bait protein experiment was repeated again for the purpose of 
testing additional combinations of E.coli lysate:TBS. Here, 200, 300, or 400µL of GST or 
GST-NSp3 were mixed with TBS up to a total volume of 500µL followed by the steps 
described above. Binding to glutathione beads was then assessed by Western 
immunoblots as described above (Figure 4). 
 
 
Figure 7. Detection of immobilized GST fusion proteins. 
anti-GST primary antibody (1:2500
~27 kDa, red arrow (B) lane show the presen
red arrows.  
These results show that the mixture containing 400µL of prot
figure 7) provided the highest binding to the glutathione beads.
Purification of the GST-NSp3 proteins
In an attempt to improve binding of the fusion protein to the glutathione agarose, 
GST-NSp3 was purified by affinity chromatography using 
Purification Kit (Pierce-Thermo Fisher Scientific) according to instructions provided by 
the manufacturer. Purification is based on the affinity of Glutathione
21 
X-ray film from a Western blot using 
). (A) Lanes 11 and 12 show the presence of GST
ce of GST at ~27 kDa and GST-NS
ein lysate (lanes 12 in 
 
 
the Pierce® GST Spin 
-S-transferase 
 
 protein at 
p3 at ~48 kDa, 
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(GST) for glutathione.  Briefly, glutathione spin columns were centrifuged at 700 x g for 
2 minutes in order to remove the storage buffer. Next, for equilibration, two resin-bed 
volumes relative to resin of kit supplied Equilibration/Wash Buffer (containing Tris-HCL, 
sodium chloride, pH8) was added to the columns, mixing by repeated inversions 
followed by centrifugation at 700 x g for 2 minutes. GST-NSp3 lysate (1 mL) obtained 
from E.coli was mixed in a 1:1 volume ratio with kit provided equilibration/ wash buffer.  
For binding, the lysate:buffer mixture was then applied to a equilibrated glutathione 
purification column followed by incubation at room temperature for 30 minutes with 
shaking in an orbital shaker. For elution purposes, the column was centrifuged at 700 x 
g for 2 minutes and flow through buffer collected in a centrifuge tube. The column was 
then washed with two resin-bed volumes of Equilibration/Wash Buffer, centrifuging at 
700 x g for 2 minutes and collecting fraction in a centrifuge tube. This washing step was 
repeated two more times. GST-NSp3 protein was eluted from the resin by adding one 
resin-bed volume of Elution Buffer (10X Glutathione stock solution provided with the kit 
10-fold with Equilibration/Wash Buffer). Centrifuge at 700 × g for 2 minutes and 
collecting the flow-through. This step was repeated two more times, collecting each 
fraction in a separate tubes.  
For assessing purity of GST-NSp3 collected fractions were resolved by SDS-
PAGE. Fractions (13µL) were combined with 5µL of SDS sample buffer, and 2µL of 
reducing agent (Life Technologies). The gel was run at 200V for 50 minutes and 
proteins transferred to PVDF membranes as described above. The presence of GST-
NSp3 was determined by using an anti-GST antibody. No GST-NSp3 proteins were 
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detected in the blots. Thus, our experiments continued using crude extracts from E.coli 
expressing GST-NSp3.  
Preparation of “prey” proteins from mammalian cells 
The purpose of this experiment was to detect cellular proteins from mammalian 
MARC-145 cells that bind to PRRSV NSp3.  
First, two different lysis buffers were tested for preparing lysates of cultured 
MARC-145 cells.  
Cell monolayers containing approximately 107 cells were washed once with 5mL 
of 1X PBS (phosphate buffered saline pH 7.2). Cells were then detached from the flask 
using 2ml of 1X Trypsin-EDTA incubating at 370C (~ 2 minutes). Four milliliters of 
complete tissue culture media (DMEM-10% fetal calf serum + antibiotics) were added to 
the flask and the entire volume was transferred to a 15mL centrifuge tube. Cells were 
centrifuged at 500 x g for 5 minutes, and supernatants discarded. Cell pellets were 
washed by adding 5mL of 1X PBS followed by centrifugation at 500 x g for 5 minutes. 
This step was repeated once.  
After washing cells were resuspended in 3mL of RIPA buffer (Sigma-Aldrich) or 
3mL of Cell Lytic B Buffer (Sigma-Aldrich) containing 20µL of lysozyme. Cells were then 
incubated on ice for 30 minutes with shaking in an orbital shaker. After incubation, tubes 
were centrifuged for 5 minutes at 12,000 x g to remove cellular debris. Supernatants 
were transferred to clean tubes and stored at -200C until use. Aliquots of these lysates 
were resolved by SDS-PAGE and gels stained with Simply Blue (Invitrogen) to visualize 
cellular proteins. Higher protein yields were obtained when Cell Lytic B Buffer was used 
to prepare the lysates. 
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Capture of cellular proteins with Glutathione-GST-NSp3 beads 
 To capture cellular proteins with Glutathione-GST-NSp3 beads, a 1:1 volume 
mixture containing 400µL of MARC-145 cell lysates: 400µL of TBS was added to the 
beads. The mixture was then incubated in ice for 1 hour with shaking using an orbital 
shaker. After incubation, mixtures were centrifuged for 1 minute at 1250 x g and the 
supernatants saved as “prey flow-through GST” and “prey flow-through GST-nsp3”. 
Next, 400µL of Wash Buffer was added to the tubes for washing the beads while gently 
mixing by repeated inversions. Tubes were centrifuged at 1250 x g for 30 seconds and 
supernatants were removed and discarded. This washing step was repeated 5 times.  
 After the last wash, the supernatant was discarded and agarose beads were 
incubated at 700C for 10 minutes in the presence of 4µL of reducing agent (Life 
Technologies) and 10µL of SDS sample buffer to elute bound proteins. Eluted proteins 




Figure 8. SDS PAGE Gel stained with 
interact with GST or GST-NSp3. 
3- “bait” GST protein; 4- “bait: GST
NSp3; 7- empty lane; 8- wash 1 GST; 9
elute; 12- BSA (bovine serum albumin).
Figure 9. Same as in figure 8 with increased contrast.
that was excised for identification of cellular proteins using mass spectrometry (see below).
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Colloidal Coomasie Blue showing cellular proteins that 
Lanes: 1- Molecular weight marker; 2- MARC-145 cell lysate; 
-NSp3 protein; 5- flow-through GST; 6- flow-through GST
- wash 2 GST-NSp3; 10- GST elute; 11-
 







Identification of cellular proteins that bind to PRRSV-NSp3 
Elucidating the function of viral proteins involves determining the role of these 
gene products during infection. In the cell, virus encoded proteins participate in an 
extensive and intricate network of protein:protein interactions. The interaction of viral 
proteins with cellular proteins most likely determines the fate of the infection. A 
preliminary step, as it has been taken in this work, is to identify cellular proteins that 
interact with PRRSV proteins, in this case PRRSV NSp3 protein.  Here, we are 
attempting to identify these interacting cellular proteins by means of Mass 
Spectrometry. To accomplish that, “trapped” proteins by the glutathione-GST-NSp3 
capture system that was established here, cellular proteins should be recovered and 
then subject to identification. 
Recovery of cellular proteins that interact with GST-NSp3 
In-Gel Digestion using proteases 
After resolving “trapped” cellular proteins by SDS-PAGE (as described above), 
proteins were recovered from Colloidal Coomasie Blue (Life Technologies) stained gels 
by in-gel tryptic digestion using the In-Gel Tryptic Digestion Kit (Pierce-Thermo Fisher 
Scientific) according with instructions provided by the manufacturer. 
Staining SDS-PAGE gels with Colloidal Coomasie Blue 
To prepare SDS-PAGE gels for in-gel tryptic digestion, gels were stained using 
Colloidal Blue Staining Kit (Life Technologies) for high sensitive staining of proteins. 
After running, gels were washed 3 times for 5 minutes each time with ddH2O. Next, 10 
mL of fixing solution (4mL of ddH2O, 5mL of methanol, and 1mL of acetic acid) was 
added to the gels incubating for 10 minutes at room temperature with shaking. The 
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fixing solution was then removed and a Staining Solution containing 5.5mL ddH2O, 2mL 
of methanol, and 2mL of Stainer A Solution as provided with the kit, was added to gel 
incubating for 10 minutes at room temperature with shaking. After the 10 minutes of 
incubation, 0.5mL of Stainer B Solution was added to the gels that were further 
incubated overnight (~12 hours) at room temperature with shaking. After overnight 
incubation, the Staining Solution was removed and the gels were washed 3 times for 5 
minutes each time with ddH2O. Images of stained gels were captured for analysis 
purposes (Figures 8 and 9). 
In-Gel Tryptic Digestion 
Bands of interest observed in stained gels were recovered using an In-Gel 
Tryptic Digestion Kit (Pierce-Thermo Fisher Scientific). To digest the bands selected in 
the first pull-down experiment (Figure 9), stained gels were destained using a 
Destaining Buffer containing 80mg of ammonium bicarbonate, 20mL of acetonitrile, and 
20mL of ultrapure water. Using a sterile scalpel, ~1cm2 surrounding bands of interest in 
lanes 10, 11, and 12 (Figure 9) were excised from the gel and placed into tubes labeled 
GST, GST-NSp3, and BSA, respectively. Next, 200µL of the Destaining Buffer was 
added to the tubes incubating at 37°C for 30 minutes with shaking. This step was 
repeated once.  
After destaining reduction and alkylation of recovered proteins were performed. 
For reduction, 30µL of reducing buffer containing 3.3µL of TCEP  
 (Tris [2-carboxyethyl] phosphine) and 30µL of the Digestion Buffer (10mg of ammonium 
bicarbonate in 5mL of ultrapure water) was added to the tubes incubating a 600C for 10 
minutes. After cooling, the buffer was discarded. For alkylation, 30µL of 1X Alkylating 
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Buffer (5X stock: 7mg of IAA [Iodoacetamide] in 70µL of ultrapure water) diluted in 
Digestion Buffer (25 mM ammonium bicarbonate) was added to the samples that were 
incubated in the dark at room temperature for 1 hour. Alkylation buffer was then 
discarded and samples were washed by adding 200µL of Destaining Buffer followed by 
incubation at 37°C for 15 minutes with shaking. The washing step was repeated once. 
For digestion purposes, excised gel pieces were shrunk by adding 50µL of 
acetonitrile incubating for 15 minutes at room temperature. Acetonitrile was discarded 
and gel pieces were air-dried for 5 to 10 minutes. For swelling the gel pieces, 10µL of 
Activated Trypsin solution (1µL of Trypsin Working Solution [5X trypsin stock diluted in 
ultrapure water] in 9µL of Digestion Buffer) was added to the tubes that were incubated 
for 15 minutes at room temperature. Then 25µL of Digestion Buffer was added to the 
samples that were incubated at 30°C overnight with shaking. The digestion mixture, 
containing peptides, was transferred to clean tubes. At this step samples were ready for 
identification by means of Mass Spectrometry. 
Mass Spectrometry of gel recovered proteins 
Samples were submitted to the Laboratory of Mass Spectrometry and Omics 
Analysis at the Department of Chemistry, University of Connecticut for protein 
identification. Samples were processed by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) with a QSTAR Elite LC/MS/MS System (AB Sciex) and 
proteins were identified using Mascot software (Matrix Science). Mascot is a software 
search engine that uses mass spectrometry data to identify proteins from peptide 
sequence databases. By using this approach peptides were not detected or detected at 
low levels in samples obtained from the pull-down experiment (Figure 9 lanes 10 and 
29 
11), however bovine serum albumin was detected in the band excised from lane 12 
(Figure 9) as expected. Most likely, the yield of cellular proteins obtained, as observed 
in Figures 8 and 9, in the pull-down assays is low and not sufficient for detection by LC-
MS/MS. Although peptides that have no match with known proteins in the searched 
database were identified in protein samples “trapped” with glutathione-GST-NSp3 
capture setting (Table 3). Further experiments should be conducted to improve the yield 
of NSp3 binding proteins. 
Table 3. Peptide identified by LC-MS/MS data do not match to known proteins. Identified 





















 The presence of GST-NSp3 observed by Western blots after expressing GST-
NSp3 in the E. coli expression system confirmed that the transformation of BL21 cells 
was successful, and that GST-NSp3 can be efficiently expressed. This protein was used 
as “prey” to trap or capture cellular proteins in the pull-down assay developed here 
(Figure 3). Using a mouse anti-GST antibody, the Western blot showed bands of the 
expected molecular sizes. However, this GST-NSp3 proteins were only detected in 
samples that were treated with the Cell Lytic B Buffer. One possibility of the lack of 
GST-NSp3 could be from the Pull-Down Buffer’s properties not successfully working on 
a bacterial system, as it is a mammalian cell buffer. The Cell Lytic B Buffer was the lysis 
buffer of choice. 
 During the first round of GST-NSp3 and GST proteins binding and immobilization 
to glutathione agarose beads, different volumes of E.coli obtained lysates were 
combined with TBS and incubated with the glutathione beads to test for optimal binding 
conditions (Table 1). It was observed that combining at least 300µL of protein lysate 
with 200µL of TBS or less yielded the strongest signals in Western blots (Table 2 and 
Figure 7). With the purpose of improving binding of GST and GST-NSp3 to the 
glutathione beads, an attempt to purify proteins by affinity chromatography was made. 
However, the amount of protein obtained by using the Pierce® GST Spin Purification Kit 
was negligible. Further attempts should be made for improving purified protein yields. 
As a results, crude E.coli cell lysates were used in this work. 
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The pull-down assay using GST and GST-NSp3 and lysates from MARC-145 
cells was successful although yielded low amounts of cellular proteins as observed in 
figures 8 and 9. Nonetheless, proteins were purified using an in-gel tryptic digestion and 
obtained peptides were submitted for Mass Spectrometry Analysis. Although the 
amount of peptides obtained in this pull-down was low and not readily detected by the 
LC-MS/MS analysis, BSA that was used as control was detected. Also, peptides with 
not matches in the protein database were detected in samples from the GST-NSp3 pull-
down.  
Overall, the data presented here suggest that the entire process established 
including cloning, expression, binding, pull-down, in-gel digestion and LC-MS/MS 
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